Outset Medical, Inc. (OM) is a Medical - Devices company in the Healthcare sector, currently trading at $4.35. It has a SharesGrow Score of 49/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
Analyst consensus target is OM = $10 (+129.9% upside).
Valuation: OM trades at a trailing Price-to-Earnings (P/E) of -0.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.05.
Financials: revenue is $119M, +1.8%/yr average growth. Net income is $82M (loss), growing at +18.7%/yr. Net profit margin is -68.3% (negative). Gross margin is 39.1% (+23.6 pp trend).
Balance sheet: total debt is $105M against $127M equity (Debt-to-Equity (D/E) ratio 0.82, moderate). Current ratio is 6.67 (strong liquidity). Debt-to-assets is 39.5%. Total assets: $264M.
Analyst outlook: 7 / 11 analysts rate OM as buy (64%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 63/100 (Pass), Past 0/100 (Fail), Health 50/100 (Partial), Moat 44/100 (Fail), Future 73/100 (Pass), Income 10/100 (Fail).
